CCM
CELG

Credo Capital Management’s Celgene Corp CELG Stock Holding History

Credo Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$54K Buy
634
+26
+4% +$2.06K 0.23% 75
2013
Q3 		$47K Sell
608
-34
-5% -$2.38K 0.08% 75
2013
Q2 		$38K Buy
+642
New +$38.6K 0.03% 89

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Credo Capital Management's CELG Position: Q4 2013 in Review

Credo Capital Management increased its Celgene Corp (CELG) stake by 4.3% in Q4 2013, buying an estimated $2.06K and bringing the position to 634 shares worth $54K. The position accounts for 0.23% of the portfolio, ranked #75.

Credo Capital Management first reported a position in CELG in Q2 2013 and has held it in 3 quarters since. 983 funds tracked by Wall St. Rank hold CELG as of Q4 2013.

  • Credo Capital Management held 634 shares of Celgene Corp worth $54K as of Q4 2013.
  • Credo Capital Management bought 26 Celgene Corp shares in Q4 2013, an estimated $2.06K.
  • Celgene Corp made up 0.23% of Credo Capital Management's portfolio in Q4 2013, its #75 holding.
  • Credo Capital Management first reported a position in Celgene Corp in Q2 2013 and has held it in 3 quarters since.
  • 983 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2013.

Based on Credo Capital Management's 13F filing for Q4 2013, filed 24 Jan 2014.